Amphastar Pharmaceuticals, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
AMPH Nasdaq 2830 www.amphastar.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Amphastar Pharmaceuticals, Inc.

Why Amphastar Pharmaceuticals (AMPH) Stock Is Nosediving - Jan 15th, 2026 1:46 pm
A Look At Amphastar Pharmaceuticals (AMPH) Valuation After The AMP-110 License Agreement With Nanjing Hanxin - Jan 15th, 2026 1:09 pm
2 Reasons to Avoid AMPH and 1 Stock to Buy Instead - Jan 14th, 2026 9:04 pm
Amphastar Pharmaceuticals Touts Shift to Proprietary Drugs, Teases AMP-007 Launch and Baqsimi Growth - Jan 14th, 2026 4:23 pm
1 Profitable Stock Worth Your Attention and 2 Facing Headwinds - Jan 13th, 2026 9:32 pm
Why Amphastar Pharmaceuticals (AMPH) Stock Is Trading Up Today - Jan 12th, 2026 2:05 pm
Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound - Jan 12th, 2026 4:00 am
The Bull Case For Amphastar Pharmaceuticals (AMPH) Could Change Following New BofA Coverage And JPM Spotlight - Jan 10th, 2026 10:10 pm
3 Low-Volatility Stocks We Find Risky - Jan 7th, 2026 9:42 pm
Biopharma Sector Enters 2026 With Clearer Outlook, Key Catalysts, BofA Says - Jan 7th, 2026 9:21 am
Amphastar Pharmaceuticals to Present at the J.P. Morgan 2026 Healthcare Conference - Jan 7th, 2026 4:00 am
Amphastar Director Sells 16,679 Shares for $441,800 - Dec 23rd, 2025 8:07 am
Will FDA Approval of an In‑House Teriparatide Pen Reshape Amphastar Pharmaceuticals' (AMPH) Narrative? - Dec 16th, 2025 9:07 am
3 Healthcare Stocks with Questionable Fundamentals - Dec 15th, 2025 9:34 pm
Amphastar Announces FDA Approval for Teriparatide Injection - Dec 15th, 2025 4:00 am
2 Russell 2000 Stocks for Long-Term Investors and 1 Facing Challenges - Dec 11th, 2025 9:33 pm
1 Stock Under $50 Worth Your Attention and 2 We Brush Off - Dec 8th, 2025 9:34 pm
Can DefenCath Continue to Aid CorMedix's Long-Term Growth Ahead? - Dec 5th, 2025 7:23 am
Amphastar Pharmaceuticals (AMPH) Stock Trades Up, Here Is Why - Dec 3rd, 2025 1:26 pm
Amphastar Pharmaceuticals (AMPH) Jumps 6.5% After Q3 Beat and Conference Reveal—Has the Investment Case Shifted? - Nov 29th, 2025 8:11 am